glp-1 obesity drug market news today The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs The obesity rate in the

The study also recorded lifestyle factors, such as current smoking status, based on patient self-reports documented in the medical histories within the EMRs dataset

In large cohort studies, current use of incretin-based therapy was not associated with an increased risk of hospitalization for acute pancreatitis [101] or pancreatic cancer [102]

Four focus groups were held in person, conducted at The Alliance 2025 Spring Symposium in Madison, Wisconsin

Importantly, no difference in weight was observed between the rats on stevia or allulose that were receiving the standard diet (SD), suggesting that the allulose effects were specific to a Western diet